HEALTH● ELEVATEDSep 1 · Sep 1, 2026, 5:28 AM
Novartis halts autoimmune CAR-T trials following three patient deaths: WSJ
Seeking Alpha Tech · global
Novartis has halted trials for autoimmune CAR-T therapies after three patient deaths were reported. This action impacts the development of a new treatment type and raises concerns about patient safety in clinical trials.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoStates Pledge Meta $17 Billion Teen Social Media Settlement to Youth Mental Health , but Few Rules Bind Spendingmedicaldaily.com · United StatesHEALTH1h ago10 , 329 Oxfordshire patients faced ambulance delays in yearwitneygazette.co.uk · United KingdomHEALTH1h agoCan a positive mindset protect us from the sniffles?New ScientistHEALTH1h agoHong Kong private healthcare providers face new rules to make fees more transparentSouth China Morning Post